UT Dell Medical School study helps solve question of when to start blood thinners after a stroke in someone with AFib.

ZUNVEYL was approved in July 2024 by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate dementia of the Alzheimer’s type in adults. As a new generation of ...